PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-Cell Transplantation and Acute Leukaemia

This study has been completed.

Study NCT00362544 Information provided by Gilead Sciences

First Received: May 10, 2006 Last Updated: October 6, 2006 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2006
Estimated Primary Completion Date:	No date given